Skip to main content
Ronny Drapkin, MD, Pathology, Philadelphia, PA

RonnyIsaacDrapkinMDPhD

Pathology Philadelphia, PA

Anatomic Pathology, Clinical Pathology

Associate Professor (tenured), Director - Penn Ovarian Cancer Research Center, Director - Gynecologic Cancer Research, Basser Center for BRCA, University of Pennsylvania

Dr. Drapkin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Drapkin's full profile

Already have an account?

Summary

  • Dr. Ronny Drapkin is a physician-scientist in Philadelphia, PA affiliated with the University of Pennsylvania Perelman School of Medicine. He received his MD and PhD degrees from Rutgers Robert Wood Johnson Medical School followed by a residency in Pathology at the Brigham & Women's Hospital in Boston. He completed a postdoctoral fellowship at the Dana-Farber Cancer Institute before joining the faculty at Harvard Medical School and the DFCI. He was recruited to Penn in 2015. He also speaks multiple languages, including Spanish. He specializes in anatomic pathology. He has more than 230 publications and over 30,000 citings.

Education & Training

  • Dana-Farber Cancer Institute
    Dana-Farber Cancer InstitutePost-Doctoral Fellowship, Cancer Biology, 2001 - 2006
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1998 - 2001
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 1998
  • Rutgers Graduate School of Biomedical Sciences
    Rutgers Graduate School of Biomedical SciencesPhD, Biochemistry, 1992 - 1996
  • Brandeis University
    Brandeis UniversityBA, 1986 - 1990

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2001 - 2016

Awards, Honors, & Recognition

  • Inducted Member American Association of Physicians (AAP), 2023
  • Rosalind Franklin Prize for Excellence in Ovarian Cancer Research Ovarian Cancer Research Fund Alliance, 2017
  • Inducted Member American Society for Clinical Investigation (ASCI), 2016
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Primordial Germ Cells as a Potential Shared Cell of Origin for Mucinous Cystic Neoplasms of the Pancreas and Mucinous Ovarian Tumors  
    Leona A Doyle, Daniel W Cramer, Michael Goggins, Ronny Drapkin, Jason L Hornick, Kevin M Elias, Michael Birrer, Michelle S Hirsch, The Journal of Pathology

Press Mentions

  • Six Warning Signs of Ovarian Cancer
    Six Warning Signs of Ovarian CancerMay 8th, 2023
  • Five Bizarre Warning Signs of Ovarian Cancer Revealed
    Five Bizarre Warning Signs of Ovarian Cancer RevealedMarch 7th, 2023
  • Five Bizarre Warning Signs of Ovarian Cancer Revealed
    Five Bizarre Warning Signs of Ovarian Cancer RevealedMarch 7th, 2023
  • Join now to see all

Grant Support

  • PROTEOMIC GENETIC AND LONGITUDINAL PATHS TO OVARIAN CANCER BIOMARKER DISCOVERYNATIONAL CANCER INSTITUTE2014–Present
  • PACIFIC OVARIAN CANCER RESEARCH CONSORTIUMNATIONAL CANCER INSTITUTE1999–Present
  • Cyclin E1 as a Therapeutic Target in Women with High-Grade Serous Ovarian Cancer and Primary Treatment FailurePMCC/Dept. of the Army – USAMRAA2015–2018
  • Cyclin E: Targeting Cell Cycle Dependencies in Ovarian CancerAdelson Medical Research Foundation (AMRF)2014–2017
  • ELAFIN AS A BIOMARKER IN SEROUS OVARIAN CANCERS AND BASAL-LIKE BREAST TUMORSNational Cancer Institute (NCI)2013–2015
  • BACH1 Function In DNA Repair And Mammary OncogenesisNational Cancer Institute2005–2009

Professional Memberships

Other Languages

  • Spanish